Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Feb 15, 2022; 14(2): 498-510
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.498
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.498
Variable | FUCA1 expression | MMP-9 expression | ||||
Low expression (n = 29) | High expression (n = 90) | P value | Low expression (n = 57) | High expression (n = 62) | P value | |
Age (yr, mean ± SD) | 61.2 ± 7.6 | 58.3 ± 9.2 | 0.137 | 59.5 ± 8.4 | 58.6 ± 9.4 | 0.587 |
Female, n (%) | 3 (10.3) | 18 (20.0) | 0.236 | 6 (10.5) | 15 (24.2) | 0.058 |
History of smoking, n (%) | 6 (20.7) | 33 (36.7) | 0.111 | 45 (78.9) | 35 (56.5) | 0.009a |
History of alcohol use, n (%) | 10 (34.5) | 35 (38.9) | 0.670 | 41 (71.9) | 33 (53.2) | 0.036 |
Localization, n (%) | ||||||
Upper | 2 (6.9) | 12 (13.3) | 0.360 | 5 (8.8) | 9 (14.5) | 0.555 |
Middle | 20 (69.0) | 49 (54.4) | 33 (57.9) | 36 (58.1) | ||
Lower | 7 (24.1) | 29 (32.2) | 19 (33.3) | 17 (27.4) | ||
Grade, n (%) | ||||||
Well | 4 (13.8) | 19 (21.1) | 0.648 | 12 (21.1) | 11 (17.7) | 0.820 |
Moderately | 16 (55.2) | 48 (53.3) | 31 (54.4) | 33 (53.2) | ||
Poorly | 9 (31.0) | 23 (25.6) | 14 (24.6) | 18 (29.0) | ||
T stage, n (%) | ||||||
T1-2 | 6 (20.7) | 22 (24.4) | 0.678 | 12 (21.1) | 16 (25.8) | 0.541 |
T3-4a | 23 (79.3) | 68 (75.6) | 45 (78.9) | 46 (74.2) | ||
Lymphatic invasion, n (%) | ||||||
Negative (N0) | 20 (69.0) | 34 (47.8) | 0.003a | 31 (54.4) | 23 (37.1) | 0.067 |
Positive (N+) | 9 (31.0) | 56 (62.2) | 26 (45.6) | 39 (62.9) | ||
TNM stage, n (%) | ||||||
I-II | 18 (62.1) | 35 (38.9) | 0.029a | 29 (50.9) | 24 (38.7) | 0.182 |
III | 11 (37.9) | 55 (61.1) | 28 (49.1) | 38 (61.3) | ||
Postoperative complication, n (%) | ||||||
Arrhythmia | 5 (17.2) | 22 (24.4) | 0.421 | 16 (28.1) | 11 (17.7) | 0.179 |
Pneumonia | 1 (3.4) | 11 (12.2) | 0.172 | 5 (8.8) | 7 (11.3) | 0.649 |
Anastomotic leak | 0 (0) | 11 (12.2) | 0.048a | 4 (7.0) | 7 (11.3) | 0.421 |
Adjuvant therapy, n (%) | 19 (65.5) | 61 (67.8) | 0.822 | 36 (63.2) | 44 (71.0) | 0.365 |
FUCA1 total score (mean ± SD) | - | - | - | 4.3 ± 3.8 | 7.3 ± 4.1 | 0.000a |
High FUCA1 expression, n (%) | - | - | - | 36 (63.2) | 54 (87.1) | 0.002a |
MMP-9 total score (mean ± SD) | 3.6 ± 2.7 | 2.3 ± 2.6 | 0.029a | - | - | - |
High MMP-9 expression, n (%) | 8 (27.6) | 54 (60.0) | 0.002a | - | - | - |
- Citation: Yu XY, Lin SC, Zhang MQ, Guo XT, Ma K, Wang LX, Huang WT, Wang Z, Yu X, Wang CG, Zhang LJ, Yu ZT. Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma. World J Gastrointest Oncol 2022; 14(2): 498-510
- URL: https://www.wjgnet.com/1948-5204/full/v14/i2/498.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i2.498